Raymond M. Withy Promoted To President Of Abgenix
Abgenix, Inc. (Nasdaq: ABGX) today announced the promotion of Raymond M. Withy, Ph.D. to President and Chief Operating Officer of Abgenix, succeeding R. Scott Greer, who will continue as Chief Executive Officer and Chairman of the Board.
Dr. Withy has served as Chief Business Officer of the company since January 2000 and as Vice President of Corporate Development since its inception in June 1996. Dr. Withy joined Abgenix when it began operating independently from Cell Genesys, where he previously served as Director of Business Development.
R. Scott Greer, Abgenix’s Chairman and Chief Executive Officer said, "Ray has been a significant force in the company since the beginning and continues to contribute to our goal of building a new biotech powerhouse. Over the past four years, he played an important role in building our business operations, including establishing collaborations with more than two dozen genomics, pharmaceutical and biotech partners. I am delighted to see Ray move into his new role where he will continue to contribute to Abgenix’s growth and progress."
Dr. Withy has over 16 years experience in the biotechnology industry. Prior to Abgenix and Cell Genesys, Dr. Withy held various research and development positions at Genzyme Corporation and Integrated Genetics, Inc. Dr. Withy received his Ph.D. in Biochemistry from the University of Nottingham in the U.K. and was a post-doctoral fellow at the California Institute of Technology.
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
